Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
820.00    -11.00 (-1.32%)
Bid:
816.00
Ask:
822.00
Spread: 6.00 (0.735%)
Market Cap: £774.61m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

15 Apr 2021 07:00

RNS Number : 5118V
Polar Capital Holdings PLC
15 April 2021
 

 

15 April 2021 Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AuM") for the financial year to 31 March 2021.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 March 2021 its AuM were £20.9bn compared to £12.2bn at the end of March 2020, an increase of 71% over the year. During the period, AuM increased by £8.7bn which comprised net subscriptions of £2.1bn, inflows from reported acquisitions of £1.7bn, offset by outflows from a previously reported fund closure of £0.3bn and an increase of £5.2bn related to market movement and fund performance.

 

AuM movement in twelve months to 31 March 2021

Long-only

funds

Alternative

funds

Total

AuM at 1 April 2020

£11,078m

£1,083m

£12,161m

Net subscriptions/(redemptions)

£2,130m

£(22)m

£2,108m

Reported acquisitions

£1,618m

£81m

£1,699m

Closure of fund

-

£(301)m

£(301)m

Market movement and performance

£5,023m

£173m

£5,196m

Total AuM at 31 March 2021

£19,849m

£1,014m

£20,863m

 

 

 

Gavin Rochussen, Chief Executive, commented:

 

"AuM increased by 10% over the quarter to 31 March and by 71% over the year from £12.2bn on 1 April 2020 to £20.9bn on 31 March 2021. The increase in AuM of £8.7bn comprised net inflows of £2.1bn, an increase of £1.7bn due to the arrival of the Phaeacian and Dalton teams, a reduction of £0.3bn due to a fund closure, and market movement and fund performance added £5.2bn.

 

"We are pleased to report a good finish to the financial year in terms of flow momentum with net inflows into 14 of our funds amounting to £643m in the quarter ended 31 March. The fact we have also increased our AuM to over £20bn, doubling the size of our business over three and a half years, is testament to our strategic focus of offering a diversified range of funds whilst maintaining a rigorous focus on performance and active management.

 

 

"It is also pleasing that the pipeline for flows into our Emerging Markets Stars range of funds, which have sustainability at the core of their processes, continues to remain strong as the funds approach their three-year track records at Polar Capital.

 

"Fund performance across our fund range in the current calendar year is resilient with 57% of our funds outperforming benchmark calendar year to date.

 

"On a three-year annualised basis, 78% of AuM has performed ahead of benchmark at the end of March.

 

"70% of AuM in our UCITS fund range is ranked in the first quartile against peers in the Lipper universe over three years.

 

"The integration of the Dalton business onto the Polar Capital platform continues according to schedule and is anticipated to be completed by our financial half-year end.

 

"We remain confident that with our diverse range of funds and focus on performance in our actively managed complementary funds we are positioned to continue to perform well for our clients and will continue to generate net inflows. The net inflow momentum of the last quarter has continued into the first two weeks of April."

 

Polar Capital aims to announce its results for the financial year to 31 March 2021 on 1 July 2021.

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (Executive Director)

Samir Ayub (Finance Director)

+44 (0)20 7227 2700

 

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

 

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Rishi Shah

 

+44 (0)20 3597 8680

 

Camarco

Ed Gascoigne-Pees

Jennifer Renwick

Monique Perks

 

+44 (0)20 3757 4995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXLLFFFFEFA
Date   Source Headline
19th Mar 202012:03 pmRNSPrice Monitoring Extension
12th Mar 20208:37 amRNSIssue of Equity
2nd Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20204:41 pmRNSSecond Price Monitoring Extn
28th Feb 20204:36 pmRNSPrice Monitoring Extension
21st Feb 202011:51 amRNSForm 8.3 - Redde PLC
21st Feb 20209:59 amRNSIssue of Equity
20th Feb 20201:54 pmRNSForm 8.3 - Redde PLC
18th Feb 202011:14 amRNSForm 8.3 - Redde PLC
18th Feb 202010:28 amRNSChange of Auditor
17th Feb 20202:44 pmRNSForm 8.3 - Redde PLC
13th Feb 20202:37 pmRNSIssue of Equity
13th Feb 20207:00 amRNSTeam Acquisition
7th Feb 20201:09 pmRNSForm 8.3 - Redde PLC
6th Feb 20202:45 pmRNSForm 8.3 - Redde PLC
5th Feb 20202:33 pmRNSForm 8.3 - Redde PLC
3rd Feb 202011:14 amRNSBlock listing Interim Review
28th Jan 20201:06 pmRNSForm 8.3 - Redde PLC
22nd Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
21st Jan 20202:26 pmRNSForm 8.3 - Redde PLC
21st Jan 20202:12 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20202:01 pmRNSForm 8.3 - Consort Medical PLC
20th Jan 20201:37 pmRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Redde PLC
17th Jan 202011:13 amRNSForm 8.3 - Consort Medical PLC
16th Jan 202012:28 pmRNSForm 8.3 - Redde PLC
16th Jan 202012:26 pmRNSForm 8.3 - Consort Medical PLC
15th Jan 202012:20 pmRNSForm 8.3 - Redde PLC
14th Jan 202012:00 pmRNSForm 8.3 - Redde PLC
13th Jan 20201:49 pmRNSForm 8.3 - Redde Plc
10th Jan 20201:09 pmRNSForm 8.3 - Redde Plc
9th Jan 20207:00 amRNSAuM Update
30th Dec 201912:35 pmRNSForm 8.3 - Redde PLC
24th Dec 201911:35 amRNSForm 8.3 - Redde PLC
23rd Dec 20193:24 pmRNSForm 8.3 - Redde PLC
20th Dec 201911:18 amRNSForm 8.3 - Redde PLC
19th Dec 20192:17 pmRNSForm 8.3 - Redde PLC
18th Dec 20191:42 pmRNSForm 8.3 - Consort Medical PLC
17th Dec 201910:58 amRNSForm 8.3 - Consort Medical Plc
17th Dec 20199:37 amRNSHolding(s) in Company
6th Dec 20191:09 pmRNSForm 8.3 - Consort Medical Plc
5th Dec 20192:24 pmRNSForm 8.3 - Consort Medical Plc
4th Dec 20191:22 pmRNSForm 8.3 - Consort Medical Plc
2nd Dec 20191:59 pmRNSForm 8.3 - Redde PLC
2nd Dec 20197:00 amRNSTotal Voting Rights
25th Nov 20197:00 amRNSUnaudited interim results
20th Nov 20194:40 pmRNSSecond Price Monitoring Extn
20th Nov 20194:35 pmRNSPrice Monitoring Extension
20th Nov 20191:52 pmRNSBlock Listing Application
20th Nov 20191:30 pmRNSCrystallisation of Business Unit & Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.